Sonire Therapeutics
What matters now
- $18Mannounced
Announced a Series A ($18M round) on 15 Apr 2026.
A company that just raised has fresh capital, a new board and new vendors to choose.
FactPress release wires (PR Newswire, GlobeNewswire)For Investors, lenders, service providersFinancing history → - 2 investorsnamed
2 investors on record; Sante Ventures led a round.
The investors already on the cap table shape who leads the next round.
Facts
- Year of incorporation
- unknown
- Revenue range (Form D)
- unknown
- Rounds on record
- 1
- Disclosed raised
- $18.0Msum of rounds with a disclosed amount only
- Named investors
- 2
Financing history
- Apr 15, 2026Series A · $18.0M (disclosed)Sante Ventures (lead)Fast Track Initiative (participant) via Koji YasudaFact Press release · “Sonire Therapeutics Closes $18 Million Series A Financing to Advance Breakthrough HIFU Therapy for Pancreatic Cancer, Expands U.S. Clinical Development”
Investors on record
- Fast Track Initiative round, participant, Koji Yasuda (confirmed) Fact prnewswire.com
- Sante Ventures round, lead Fact prnewswire.com
Ownership and outcomes
How these are wordedA company a buyout or growth firm lists on its own site is “listed in the portfolio of”, never “acquired by”. A date prints only when a deal record gives one; otherwise the row says when DFX first saw it.No firm portfolio page lists this company, so no outcome is stated.
Credit relationships
How a loan is matchedA BDC reports its loans by borrower name. A position shows here only when the match passed a precision gate (a hand-labelled sample was 29 of 30 correct); the tier and confidence are printed on each row. Amounts are the lender’s reported position, never a round.People
- Tohru Satoh President and CEO prnewswire.com
Timeline
- Apr 15, 2026Sonire Therapeutics announced Series A of $18,000,000, led by Santé VenturesRound announced Fact Press release
Evidence
Every observation on this company
- Round announced: Series A $18,000,000 Apr 15, 2026 Fact Press release
Relationships across DFX
2 capital paths
Sonire Therapeutics sits on 2 traced paths of capital across the graphs.
DFX traced 2 paths of capital through this record
Every record on each path, what it committed or lent, and as of when.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
Derived from allocator disclosures, BDC schedules and SEC filings; confidence is the weakest hop.
Checking your plan…
Record history
- Round announced2026-04-15source on record
The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.